Abstract 1852: CRISPR screening identifies BMF loss as a drug-tolerant persister cell survival factor in ALK-rearranged lung cancer.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Ryohei Katayama, Takahiro Utsumi, Ken Uchibori, Makoto Nishio
Institution: Japanese Foundation For Cancer Research
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148666309
Cites:
Cited by:
Related to: